Cargando…

Circulating Galectin‐3 Is Associated With Cardiometabolic Disease in the Community

BACKGROUND: Circulating Galectin‐3 (Gal‐3) concentrations are associated with an increased incidence of heart failure, atrial fibrillation, chronic kidney disease, and mortality. Recent evidence suggests that Gal‐3 may also be an important modulator of cardiometabolic traits such as adiposity, insul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nayor, Matthew, Wang, Na, Larson, Martin G., Vasan, Ramachandran S., Levy, Daniel, Ho, Jennifer E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859357/ https://www.ncbi.nlm.nih.gov/pubmed/26722123 http://dx.doi.org/10.1161/JAHA.115.002347

Ejemplares similares

Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community
por: Gonzalez Izundegui, Daniel, et al.
Publicado: (2022)

Association of Cardiometabolic Disease With Cancer in the Community
por: Liu, Elizabeth E., et al.
Publicado: (2022)

Left Ventricular Diastolic Dysfunction in the Community: Impact of Diagnostic Criteria on the Burden, Correlates, and Prognosis
por: Nayor, Matthew, et al.
Publicado: (2018)

Association of Variability in Body Mass Index and Metabolic Health With Cardiometabolic Disease Risk
por: Sponholtz, Todd R., et al.
Publicado: (2019)

Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes
por: Ho, Jennifer E., et al.
Publicado: (2016)

Circulating Microbiota in Cardiometabolic Disease
por: Sumida, Keiichi, et al.
Publicado: (2022)

Circulating Galectin-3 Evaluation in Dogs With Cardiac and Non-cardiac Diseases
por: Lee, Ga-Won, et al.
Publicado: (2021)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
por: Sundblad, Victoria, et al.
Publicado: (2021)

Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease
por: Walker, Rebecca L., et al.
Publicado: (2021)

Circulating Metabolites May Illustrate Relationship of Alcohol Consumption with Cardiovascular Disease
por: Li, Yi, et al.
Publicado: (2023)

Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
por: Lieb, Wolfgang, et al.
Publicado: (2018)

Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease
por: Taylor, Christy N., et al.
Publicado: (2023)

Genetic determinants of circulating galectin‐3 levels in patients with coronary artery disease
por: Liao, Yu‐Huang, et al.
Publicado: (2020)

Association of mitochondrial DNA copy number with cardiometabolic diseases
por: Liu, Xue, et al.
Publicado: (2021)

Circulating metabolites may illustrate relationship of alcohol consumption with cardiovascular disease
por: Li, Yi, et al.
Publicado: (2023)

Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study
por: Kammerlander, Andreas A., et al.
Publicado: (2021)

Association of Estimated Cardiorespiratory Fitness in Midlife With Cardiometabolic Outcomes and Mortality
por: Lee, Joowon, et al.
Publicado: (2021)

Relation of Central Arterial Stiffness to Incident Heart Failure in the Community
por: Tsao, Connie W., et al.
Publicado: (2015)

Depression in type 1 diabetes was associated with high levels of circulating galectin-3
por: Melin, Eva Olga, et al.
Publicado: (2018)

Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort
por: Andersson, Charlotte, et al.
Publicado: (2015)

Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic Dysfunction
por: Lau, Emily S., et al.
Publicado: (2021)

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
por: Duckworth, Carrie A., et al.
Publicado: (2015)

Association of Circulating Ceramides With Cardiac Structure and Function in the Community: The Framingham Heart Study
por: Nwabuo, Chike C., et al.
Publicado: (2019)

Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community
por: Kaess, Bernhard M., et al.
Publicado: (2015)

Galectin-3 in Cardiovascular Diseases
por: Blanda, Valeria, et al.
Publicado: (2020)

Association of Circulating Adipokines With Echocardiographic Measures of Cardiac Structure and Function in a Community‐Based Cohort
por: von Jeinsen, Beatrice, et al.
Publicado: (2018)

Causal associations of circulating adiponectin with cardiometabolic diseases and osteoporotic fracture
por: Zhang, Muzi, et al.
Publicado: (2022)

Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation
por: Opotowsky, Alexander R., et al.
Publicado: (2016)

Risk factor-based subphenotyping of heart failure in the community
por: Andersson, Charlotte, et al.
Publicado: (2019)

Adiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study
por: Cheng, Susan, et al.
Publicado: (2010)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
por: Nguyen, My-Nhan, et al.
Publicado: (2018)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

Galectin-3 and galectin-3 binding protein in rheumatoid arthritis
por: Ohshima, S, et al.
Publicado: (2003)

IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
por: Borovcanin, Milica M., et al.
Publicado: (2018)

Metabolomic signatures of cardiac remodelling and heart failure risk in the community
por: Andersson, Charlotte, et al.
Publicado: (2020)

Conjoint Associations of Adherence to Physical Activity and Dietary Guidelines With Cardiometabolic Health: The Framingham Heart Study
por: Lee, Joowon, et al.
Publicado: (2021)

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
por: Suthahar, Navin, et al.
Publicado: (2018)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

Association of Circulating Tissue Inhibitor of Metalloproteinases‐1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease
por: Lieb, Wolfgang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t22n7hu4c4bafsagn7i7776llo